Gastrointestinal Pathogen Testing Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact
Discover trends, market shifts, and competitive outlooks for the gastrointestinal pathogen testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Milestones in the Gastrointestinal Pathogen Testing Market’s Growth Trajectory From 2025 To 2034?
In recent years, there has been a steady expansion in the market size of gastrointestinal pathogen testing. The projections indicate a growth from $4.05 billion in 2024 to $4.24 billion in 2025, representing a compound annual growth rate (CAGR) of 4.6%. This growth trajectory in previous years can be linked to several factors such as a rise in gastrointestinal infection cases, an increased awareness of foodborne diseases, a surge in travel-related infections due to globalization, regulatory measures aimed at food safety, an escalation in healthcare spending, and an increased demand for fast and accurate diagnostic solutions.
Anticipated to experience consistent growth over the next several years, the market size of gastrointestinal pathogen testing is predicted to reach $5.01 billion by 2029, with a compound annual growth rate (CAGR) of 4.3%. This projected growth during the forecast period can be traced back to a variety of factors. These include the escalating frequency of gastrointestinal infections worldwide, increased consciousness about the significance of early recognition and treatment, the growth of healthcare facilities in developing economies, a surge in demand for point-of-care testing solutions, a heightened emphasis on food safety norms, and ongoing research and innovation efforts. Some key trends expected to characterize the forecast period are swift testing methods, rising acceptance of molecular diagnostic methods, the proliferation of point-of-care testing in non-conventional healthcare settings, progress in automation and robotics for efficient testing procedures, the advent of innovative biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine learning algorithms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp
Which Primay Drivers Are Accelerating Growth in the Gastrointestinal Pathogen Testing Market?
The increasing prevalence of foodborne illnesses is anticipated to drive the expansion of the gastrointestinal pathogen testing market. These diseases are typically induced by the ingestion of food or drinks contaminated with pathogenic microbes, toxins, or chemicals, including illnesses like listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The upswing in such diseases can be attributed to several factors, such as changes in the methods of food production, distribution, and consumption, insufficient food safety precautions, and the effect of climate change on food production. These gastrointestinal tests can identify the exact pathogens causing these foodborne diseases, assisting healthcare professionals in determining the reasons for gastrointestinal symptoms, establishing the right treatment, tracking outbreaks, and formulating measures to prevent the further spread of these diseases. For example, in February 2024, the UK Health Security Agency, a government organisation based in the UK, stated that England and Wales had 167 listeriosis cases in 2022 as opposed to 160 cases in 2021. Hence, the escalating rates of foodborne illnesses are fuelling the expansion of the gastrointestinal pathogen testing market.
How Is the Gastrointestinal Pathogen Testing Market Segmented?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp
Which Regions Are Key Players in the Growth of the Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Gastrointestinal Pathogen Testing Market?
Leading firms in the gastrointestinal pathogen testing market are centered around creating advanced solutions such as metagenomic diagnostic tests to improve the precision, speed, and inclusiveness of identifying gastrointestinal pathogens. Metagenomic diagnostics is sophisticated technology that scrutinizes the genome of microorganisms from a sample, such as blood or stool. For example, Microba Life Sciences, a biotech company based in Australia, in April 2024 rolled out MetaPanel which is a metagenomic diagnostic test designed to detect numerous gastrointestinal pathogens with exceptional accuracy. The MetaPanel encompasses 175 pathogen targets in one test, providing medical professionals a complete solution to diagnose both usual and elusive infections. It uses the Next-Generation Sequencing (NGS) technology to examine a vast range of genetic material in a stool sample. This enables the identification of a plethora of potential pathogens, including those not normally checked for in conventional gastrointestinal panels.
View the full report here:
How Is the Gastrointestinal Pathogen Testing Market Defined and What Are Its Core Parameters?
Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
